Healthcare with Confidence
Top Breast Cancer Specialists in Israel in 2025
Expert Care from Leading Oncologists and Surgeons
In 2025, Israel continues to be a global leader in advanced breast cancer treatment. We are renowned for our cutting-edge medical treatments and highly skilled healthcare professionals, the world’s leading experts in breast oncology, surgery and radiotherapy.
We collaborate with such known professionals in breast cancer field as Prof. Moshe Papa, Prof. Ella Evron, Dr. Noa Efrat Ben Baruch, Prof. Ido Wolf and many others.
Whether you’re seeking a diagnosis, treatment plan, or a second opinion, these top doctors offer world-class care tailored to your needs.
Choose your doctor and contact us ⇒ 10 Best Doctors for Breast Cancer Treatment in Israel in 2025
If you want to get a Second Opinion of the leading Israeli breast cancer specialist, please provide your medical summary, including treatments done and results, medical files, blood tests, pathology reports, PET CT, MRI reports in English and CDs. We will promptly organize consultation.
Advanced treatment of Any Type, Stage and Differentiation, BRCA, non-BRCA:
Innovative Treatments for Breast Cancer in Israel in 2025
Breast cancer is one of the most common types of cancer among women.
However, recent years have seen remarkable advancements in its treatment in Israel. With the integration of advanced technologies, groundbreaking research, and personalized therapeutic approaches, our international patients now enjoy improved quality of life and higher recovery rates.
1. Personalized Immunotherapy
Immunotherapy, which aims to enhance the immune system’s ability to identify and attack cancer cells, remains one of the most promising avenues in breast cancer treatment.
In Israel recently, several immunotherapy drugs Keytruda and Tecentriq which are inhibitors of PDL-1 have been shown to be effective in a minority of breast tumors.
⇒ More detailed about Immunotherapy for Breast Cancer in 2025
2. Targeted Biological Therapies
Advanced biological therapy focuses on targeting the cellular mechanisms of cancer cells. Israel has developed new biological drugs, such as HER2 inhibitors, which are specifically designed for women with HER2-positive cancers.
While chemotherapy drugs damage the cell division mechanism in general, biological drugs target and attack only cancer cells and therefore cause fewer side effects.
Medications like Perjeta, Kadcyla, Herceptin, Tykerb, Enhertu prevent HER-2 expression on cancer cells and their development. Some of the biological drugs are combined with chemotherapy to maximize treatment effectiveness.
A combination of Herceptin and DM1 is given as a treatment for metastatic breast cancer in advanced treatment lines.
⇒ More detailed about Targeted Therapy for Breast Cancer in 2025
3. Advanced Radiology Technologies
Israel leads in the use of innovative radiology technologies, such as SBRT (Stereotactic Body Radiation Therapy) and IGRT (Image-Guided Radiation Therapy). These approaches integrate real-time imaging to direct radiation precisely at the tumor, minimizing damage to surrounding healthy tissues. Such methods reduce side effects and enable faster recovery.
4. Minimally Invasive Surgeries
The use of robotic and minimally invasive surgical techniques is increasing in Israel, allowing precise tumor removal while preserving breast tissue. Additionally, advanced breast reconstruction procedures ensure improved aesthetic and physical outcomes.
More details about surgeries in Israel, done by leading breast surgeons
5. Personalized Treatment for Breast Cancer
Personalized breast cancer treatment in Israel is based on genetic profiling. Our doctors offer tailored therapies based on the unique genetic and molecular characteristics of your cancer.
At early and late stages, our specialists focus on treatment with only those drugs that have been tested by breast cancer special oncotests and have shown their effectiveness on a particular tumor. Immunotherapy, hormone treatments, and advanced chemotherapy regimens are also customized to meet your individual needs. This innovative approach ensures optimal outcomes and improved quality of life, making Israel a global hub for personalized breast cancer care.
In Israel, the latest Oncotests for Breast Cancer are performed in accordance with the recommendations of the American Cancer Society.
Some of the tests done is Israel: EndoPredict, Oncotype DX, Tempus, Guardant 360, Caris, CTC tests, Fugene, Curesponce, FISH etc.
⇒ Oncotests for Breast Cancer in Israel
6. Clinical Trials and Breakthrough Therapies
Hospitals and research institutes in Israel offer participation in cutting-edge clinical trials, including innovative treatments like RNA-based therapies and nanotechnology for drug delivery directly to cancer cells. These methods provide solutions for women with tumors that do not respond to standard treatments.
If you want to learn abut clinical trials which are open for recruiting in Israel now, please contact us and provide your medical records. We will organize an online appointment with Breast Cancer specialist for you. The doctor will give your treatment recommendations and inform you about the clinical trials available for your case in Israel.
7. Multidisciplinary Support and Holistic Care
Israel emphasizes a holistic approach to breast cancer treatment, with multidisciplinary teams comprising oncologists, radiologists, surgeons, and mental health professionals. Personalized rehabilitation programs address physical and emotional recovery post-treatment, recognizing the importance of overall well-being.
Looking Ahead
Israel continues to lead the way in breast cancer research and development. With significant investments in innovative technologies and collaborations with leading global medical centers, the coming years are expected to bring groundbreaking solutions that will further improve the quality of life and recovery chances for women battling the disease.
Breast Cancer Diagnosis in Israel
Breast Cancer Diagnosis in 2024:
- Mammogram – test for detection of early findings of breast cancer and precancerous conditions (DCIS)
- Ultrasound – helps to detect findings in the breast that may not have been seen in a mammogram
- Breast MRI – screening test for high-risk women, such as BRCA1 or BRCA2 gene carriers starting at age 25, women with a significant family history of cancer
- Breast biopsy and Pathology – type of breast cancer, differentiation, status of hormone receptors (ER/PR), expression status of the oncogene HER-2 and other characteristics
- PET CT – whole body scanning to reveal or rule out metastases spread for stage determination
Depending on the stage, our doctor will determine the appropriate treatment method for your case.
